Ignite Creation Date:
2025-12-26 @ 10:44 PM
Ignite Modification Date:
2026-02-17 @ 9:53 PM
Study NCT ID:
NCT06517212
Status:
RECRUITING
Last Update Posted:
2024-11-27
First Post:
2024-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
Sponsor:
Baylor Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
024-273
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None